부산대학교 도서관

Gunther, Jillian R ; Xu, Jie ; Bhutani, Manoop S ; Strati, Paolo ; Fang, Penny Q ; Wu, Susan Y ; Dabaja, Bouthaina S ; Dong, Wenli ; Bhosale, Priya R ; Flowers, Christopher R ; Nair, Ranjit ; Malpica Castillo, Luis ; Fayad, Luis ; Iyer, Swaminathan P ; Parmer, Simrit ; Wang, Michael ; Lee, Hun Ju ; Samaniego, Felipe ; Westin, Jason ; Ahmed, Sairah ; Nze, Chijioke C ; Jain, Preetesh ; Neelapu, Sattva S ; Rodriguez, Maria A ; Chihara, Dai ; Nastoupil, Loretta J ; Pinnix, Chelsea C

In The Lancet Haematology July 2024 11(7):e521-e529

Chihara, Dai ; Lin, Ruitao ; Flowers, Christopher R ; Finnigan, Shanda R ; Cordes, Lisa M ; Fukuda, Yoko ; Huang, Erich P ; Rubinstein, Larry V ; Nastoupil, Loretta J ; Ivy, S Percy ; Doroshow, James H ; Takebe, Naoko

In The Lancet 13-19 August 2022 400(10351):512-521

Casulo, Carla ; Larson, Melissa C ; Lunde, Julianne J ; Habermann, Thomas M ; Lossos, Izidore S ; Wang, Yucai ; Nastoupil, Loretta J ; Strouse, Christopher ; Chihara, Dai ; Martin, Peter ; Cohen, Jonathon B ; Kahl, Brad S ; Burack, W Richard ; Koff, Jean L ; Mun, Yong ; Masaquel, Anthony ; Wu, Mei ; Wei, Michael C ; Shewade, Ashwini ; Li, Jia ; Cerhan, James ; Flowers, Christopher R ; Link, Brian K ; Maurer, Matthew J

In The Lancet Haematology April 2022 9(4):e289-e300

Wang, Michael L ; Jain, Preetesh ; Zhao, Shuangtao ; Lee, Hun Ju ; Nastoupil, Loretta ; Fayad, Luis ; Ok, Chi Young ; Kanagal-Shamanna, Rashmi ; Hill, Holly A ; Yao, Yixin ; Hagemeister, Fredrick B ; Westin, Jason R ; Fowler, Nathan ; Samaniego, Felipe ; Steiner, Raphael ; Nair, Ranjit ; Iyer, Swaminathan P ; Navsaria, Lucy ; Badillo, Maria ; Feng, Lei ; Xuelin, Huang ; Nogueras Gonzalez, Graciela M ; Xu, Guofan ; Wagner-Bartak, Nicolaus ; Thirumurthi, Selvi ; Santos, David ; Tang, Guilin ; Lin, Pei ; Wang, Sa A ; Jorgensen, Jeff ; Yin, C Cameron ; Li, Shaoying ; Patel, Keyur P ; Vega, Francisco ; Medeiros, L Jeffery ; Flowers, Christopher R ; Wang, Linghua

In The Lancet Oncology March 2022 23(3):406-415

Thanarajasingam, Gita ; Leonard, John P ; Witzig, Thomas E ; Habermann, Thomas M ; Blum, Kristie A ; Bartlett, Nancy L ; Flowers, Christopher R ; Pitcher, Brandelyn N ; Jung, Sin-Ho ; Atherton, Pamela J ; Tan, Angelina ; Novotny, Paul J ; Dueck, Amylou C

In The Lancet Haematology June 2020 7(6):e490-e497

Nastoupil, Loretta J ; Lunning, Matthew A ; Vose, Julie M ; Schreeder, Marshall T ; Siddiqi, Tanya ; Flowers, Christopher R ; Cohen, Jonathon B ; Burger, Jan A ; Wierda, William G ; O'Brien, Susan ; Sportelli, Peter ; Miskin, Hari P ; Purdom, Michelle A ; Weiss, Michael S ; Fowler, Nathan H

In The Lancet Haematology February 2019 6(2):e100-e109

Jiang, Jun Yang; Li, Ang; Romero, Alexis; Flowers, Christopher R; Nze, Chijioke

Oncologist; Jun2025, Vol. 30 Issue 6, p1-10, 10p

Toumeh N; Division of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Larson M; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Negaard B; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Casulo C; Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Maurer M; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Feldman A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Mou E; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Cohen J; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Habermann T; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lossos IS; Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL, USA.; Friedberg J; Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Kahl B; Division of Oncology, Washington University, St Louis, MO, USA.; Martin P; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cerhan JR; Division of Epidemiology/Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Williams AM; Division of Supportive Care in Cancer, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Rosenthal A; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA.; Ainsworth A; Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.; Thompson C; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Durani U; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Superdock MA; Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Rimsza LM; Department of Pathology and Laboratory Medicine, The University of Arizona, Tucson, AZ, USA.; Wallace DS; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA.; Strawderman M; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA.; Ramsower CA; Department of Pathology and Laboratory Medicine, The University of Arizona, Tucson, AZ, USA.; Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Faugh T; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA.; Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Link BK; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Rosenthal AC; Department of Internal Medicine, Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA.; Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.; Syrbu SI; Department of Pathology, University of Iowa, Iowa City, IA, USA.; Feldman AL; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, USA.; Rock PJ; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.; Robetorye RS; Department of Laboratory Medicine & Pathology, Mayo Clinic, Phoenix, AZ, USA.; Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Friedberg JW; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA.; Casulo C; Department of Medicine, Division of Hematology and Oncology, University of Rochester Medical Center James P. Wilmot Cancer Institute, Rochester, NY, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Rodriguez, Elizabeth R; Tonn, Tori; Jafry, Midhat; Ahmed, Sairah; Cuglievan, Branko; Livingston, J Andrew; Flowers, Christopher R; Aune, Gregory J; Albritton, Karen H; Roth, Michael E; Xiao, Qian; Hildebrandt, Michelle A T

JNCI Cancer Spectrum; Aug2024, Vol. 8 Issue 4, p1-8, 8p

Mondello P; Division of Hematology, Mayo Clinic, Rochester, MN, USA. mondello.patrizia@mayo.edu.; Negaard B; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Feldman AL; Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.; Link BK; Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Chihara D; MD Anderson Cancer Center, Houston, TX, USA.; Russler-Germain D; Washington University School of Medicine in St Louis, St Louis, MO, USA.; Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA, USA.; Gribbin C; Weill Cornell Medical College, New York, NY, USA.; Haddadi S; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Mou E; Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Micallef IN; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Johnston PB; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Novak J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; King RL; Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.; Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Martin P; Weill Cornell Medical College, New York, NY, USA.; Kahl B; Washington University School of Medicine in St Louis, St Louis, MO, USA.; Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Nastoupil LJ; MD Anderson Cancer Center, Houston, TX, USA.; Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Flowers CR; MD Anderson Cancer Center, Houston, TX, USA.; Lossos IS; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Burack RW; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA. ansell.stephen@mayo.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pstrati@mdanderson.org.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Malpica L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henderson J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gallardo M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rivera M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang I; BostonGene, Corp, Waltham, MA, USA.; Bolshakova A; BostonGene, Corp, Waltham, MA, USA.; Radko A; BostonGene, Corp, Waltham, MA, USA.; Kurtz D; Foresight Diagnostics Inc, Boulder, CO, USA.; Alig SK; Department of Internal Medicine III, Ludwig-Maximilian-University (LMU) Hospital, Munich, Germany.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alizadeh AA; Stanford University School of Medicine, Stanford, CA, USA.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Yang H; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arita K; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bowman K; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; University of Texas MD Ander Cancer Center UT Health Houston Graduate School of Biological Sciences, Houston, TX, USA.; Chihara D; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henderson J; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rost G; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rojas E; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parsons S; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lakra P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Abedin A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Strati P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad L; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer SP; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Malpica L; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HJ; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hilton L; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Davis RE; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Inghirami G; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY 10065, USA.; Vega F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Green MR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Thompson C; Mayo Clinic College of Medicine, Rochester, MN.; Trněný M; First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic.; Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, Lille, France.; Salles G; Memorial Sloan Kettering Cancer Center, New York City, NY.; Reagan PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY.; Hertzberg M; Prince of Wales Hospital and University of New South Wales, Sydney, Australia.; Zhang H; Tianjin Medical University Cancer Hospital, Tianjin, China.; Thieblemont C; Hemato-oncology Department, Saint-Louis Hospital, University of Paris Cité, Assistance Publique-Hôpitaux de Paris, Paris, France.; Hu B; Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC.; Fonseca G; Florida Cancer Specialists North/Sarah Cannon Research Institute, St. Petersburg, FL.; Kim WS; Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Martelli M; Hematology Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.; Mehta A; Division of Hematology and Oncology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL.; Singh A; Genentech, Inc., South San Francisco, CA.; Yan M; Hoffmann-La Roche Ltd, Mississauga, ON, Canada.; Hirata J; Genentech, Inc., South San Francisco, CA.; Sugidono M; Genentech, Inc., South San Francisco, CA.; Lee C; Genentech, Inc., South San Francisco, CA.; Sharman JP; Willamette Valley Cancer Institute/US Oncology, Eugene, OR.; Mehta-Shah N; Division of Oncology, Washington University School of Medicine, St. Louis, MO.; Flowers CR; MD Anderson Cancer Center, The University of Texas, Houston, TX.; Tilly H; Centre Henri-Becquerel and University of Rouen, Rouen, France.; Chua N; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.; Casasnovas RO; Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.; Miall F; Department of Hematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.; Kim TM; Seoul National University Hospital, Seoul, Republic of Korea.; Tsai XC; National Taiwan University Hospital, Taipei, Taiwan.; Nasta S; University of Pennsylvania Hospital, Philadelphia, PA.; Lee ST; Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, MD.; Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Kim K; Division of Cancer Medicine, The University of Texas MD Anderson, Houston, Texas, USA.; Shah R; Division of Cancer Medicine, The University of Texas MD Anderson, Houston, Texas, USA.; Ayers A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Claret L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nze C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Torres J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fayad LE; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Maurer MJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; Prochazka VK; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.; El-Galaly TC; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark.; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Villa D; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.; Bachy E; Department of Hematology, Lyon Sud Hospital, Lyon, France.; Cahn EJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.; Fournier M; Department of Biometry, Lymphoma Study Association Clinical Research (LYSARC), Hopital Lyon Sud, Pierre Benite, France.; Larson MC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.; Dietrich CE; Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Jakobsen LH; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France.; Kridel R; Princess Margaret Cancer Centre-UHN, Toronto, Ontario, Canada.; Gandhi MK; Mater Research Institute University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.; Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia.; Hawkes EA; Olivia Newton John Cancer Research Institute at Austin Health, Melbourne, Australia.; Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, Australia.; Freeman CL; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.; Clausen MR; Department of Medicine, Vejle Hospital, Vejle, Denmark.; Wahlin BE; Institution for Medicine at Huddinge, Karolinska Institutet and Medical Unit Hematology at Solna, Cancer, Karolinska University Hospital, Stockholm, Sweden.; Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY.; Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, NY.; Habermann TM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; Wang Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; Nastoupil LJ; Southwest Oncology, CommonSpirit Mercy, Durango, CO.; de Nully Brown P; Rigshospitalet, Department of Hematology, Copenhagen, Denmark.; Belada D; 4th Department of Internal Medicine-Haematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.; Janíková A; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Mocikova H; Fakultni nemocnice Kralovske Vinohrady, Department of Haematology and Third Faculty of Medicine, Charles University, Prague, Czech Republic.; Fürst T; Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic.; Feugier P; Department of Hematology; Nancy University Hospital, Vandoeuvre les nancy, France.; Tilly H; Department of Hematology and U1245, Centre Henri Becquerel, Rouen, France.; Haioun C; Lymphoid Malignancies Unit, Assistante Publique Hôpitaux de Paris APHP, Hopital Henri Mondor, Creteil, France.; Davies AJ; Cancer Sciences Division, Somers Cancer Research Building, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Cartron G; Hematology Department, University Hospital, UMR-CNRS553, Montpellier, France.; Burack R; University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY.; Chihara D; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.; Martin P; Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY.; Cohen JB; Department of Hematology and Medical Oncology, Emory University School of Medicine-Winship Cancer Institute, Atlanta, GA.; Lossos IS; Lymphoma Section, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.; Kahl BS; Washington University School of Medicine, St Louis, MO.; Sehn LH; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada.; Smedby KE; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.; Salles G; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.; Trneny M; First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic.; Link BK; Division of Hematology, Oncology, and Bone and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA.; Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France.; Cerhan JR; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Singh AP; Xiao L; O'Brien BJ; Blondeau CE; Flowers CR; Bruera E; Morris VK; Shah AY

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE; In Process

Morschhauser F; Salles G; Sehn LH; Herrera AF; Friedberg JW; Trněný M; Lenz G; Sharman JP; Herbaux C; Burke JM; Matasar M; Collins GP; Mehta-Shah N; Oberic L; Chauchet A; Jurczak W; Song Y; Pinto A; Rai S; Izutsu K; Greil R; Mykhalska L; Bergua-Burgués JM; Cheung MC; Shin HJ; Hapgood G; Munhoz E; Abrisqueta P; Gau JP; Jiang Y; McCall B; Chohan S; Sugidono M; Yan M; Lee Batlevi C; Tilly H; Flowers CR

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process

Nguyen TM; Department of Medicine, Baylor College of Medicine, Houston, TX.; Lu J; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Guffey D; Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX.; Kim R; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Oluyomi A; Section of Epidemiology & Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX.; Rosales O; Section of Epidemiology & Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX.; Bandyo R; Harris Health System, Houston, TX.; Miller-Chism CN; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Udden MM; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Mims MP; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Abuasab T; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Diamond A; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Teegavarapu PS; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.; Nze C; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.; Flowers CR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.; Li A; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX. Electronic address: ang.li2@bcm.edu.; Jiang JY; Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Gaulin C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Oriabure O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Xu G; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deswal A; Department of Geriatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iliescu C; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Badillo M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ky M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Avellaneda M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tangc G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang ML; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process